QIAGEN Gross Profit 2006-2021 | QGEN

QIAGEN annual/quarterly gross profit history and growth rate from 2006 to 2021. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • QIAGEN gross profit for the quarter ending September 30, 2021 was $0.337B, a 5.13% increase year-over-year.
  • QIAGEN gross profit for the twelve months ending September 30, 2021 was $1.450B, a 27.36% increase year-over-year.
  • QIAGEN annual gross profit for 2020 was $1.233B, a 22.63% increase from 2019.
  • QIAGEN annual gross profit for 2019 was $1.005B, a 0.43% increase from 2018.
  • QIAGEN annual gross profit for 2018 was $1.001B, a 8.5% increase from 2017.
QIAGEN Annual Gross Profit
(Millions of US $)
2020 $1,233
2019 $1,005
2018 $1,001
2017 $923
2016 $845
2015 $827
2014 $865
2013 $815
2012 $824
2011 $750
2010 $716
2009 $667
2008 $600
2007 $434
2006 $325
2005 $275
QIAGEN Quarterly Gross Profit
(Millions of US $)
2021-09-30 $337
2021-06-30 $369
2021-03-31 $371
2020-12-31 $373
2020-09-30 $321
2020-06-30 $295
2020-03-31 $244
2019-12-31 $280
2019-09-30 $255
2019-06-30 $246
2019-03-31 $225
2018-12-31 $265
2018-09-30 $257
2018-06-30 $254
2018-03-31 $226
2017-12-31 $261
2017-09-30 $241
2017-06-30 $225
2017-03-31 $196
2016-12-31 $228
2016-09-30 $221
2016-06-30 $211
2016-03-31 $185
2015-12-31 $224
2015-09-30 $205
2015-06-30 $201
2015-03-31 $198
2014-12-31 $216
2014-09-30 $223
2014-06-30 $216
2014-03-31 $210
2013-12-31 $236
2013-09-30 $211
2013-06-30 $169
2013-03-31 $200
2012-12-31 $233
2012-09-30 $199
2012-06-30 $203
2012-03-31 $189
2011-12-31 $202
2011-09-30 $188
2011-06-30 $188
2011-03-31 $172
2010-12-31 $189
2010-09-30 $181
2010-06-30 $173
2010-03-31 $173
2009-12-31 $188
2009-09-30 $173
2009-06-30 $160
2009-03-31 $146
2008-12-31 $157
2008-09-30 $153
2008-06-30 $148
2008-03-31 $141
2007-12-31 $135
2007-09-30 $116
2007-06-30 $93
2007-03-31 $89
2006-12-31 $126
2006-09-30 $82
2006-06-30 $113
2006-03-31 $109
2005-12-31 $75
2005-09-30 $69
2005-06-30 $67
2005-03-31 $64
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $12.874B $1.870B
Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $125.477B 7.93
Bio-Rad Laboratories (BIO.B) United States $23.034B 46.74
Biohaven Pharmaceutical Holding (BHVN) United States $7.457B 0.00
Arcus Biosciences (RCUS) United States $3.257B 0.00
Emergent Biosolutions (EBS) United States $2.378B 8.55
Myovant Sciences (MYOV) United Kingdom $1.780B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.529B 0.00
Zymeworks (ZYME) Canada $0.908B 0.00
Ambrx Biopharma (AMAM) United States $0.407B 0.00
SQZ Biotechnologies (SQZ) United States $0.345B 0.00
Enzo Biochem (ENZ) United States $0.164B 16.09